Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells

Cytotherapy

Volumn 9, Issue 8, 2007, Pages 795-801

  Gao, Peng ^a   Zhou, G Y ^a   Lei, D P ^b   Zhang, X F ^a   Li, Li ^a   Xu, J W ^a   Lin, X Y ^c  

^a Shandong Provincial Key Laboratory of Mental Disorders   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Antisense oligonucleotides; Breast; Cancer; Chemotherapy

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DOXORUBICIN; RHODAMINE 123; VINBLASTINE;

ARTICLE; BREAST CARCINOMA; CANCER CELL; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSAL REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; TRANSCRIPTION REGULATION;

EID: 36849045370     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701656087     Document Type: Article

References (21)

1. Peer, D. and Margalit, R. (2006) Fluoxetine and reversal of multidrug resistance. Cancer Lett, 237, pp. 180-187.
2. Kaur, P. (2002) Multidrug resistance: Can different keys open the same lock?. Drug Resist Update, 5, pp. 61-64.
3. Marzolini, C., Paus, E. and Buclin, T. (2004) Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance. Clin Pharmacol Ther, 75, pp. 13-33.
4. Xu, D., Lu, Q. and Hu, X. (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett, 243, pp. 274-280.
5. Kobayashi, H., Takemura, Y. and Miyachi, H. (2001) Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Hum Cell, 14, pp. 172-184.
6. Motomura, S., Motoji, T. and Takanashi, M. (1998) Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides. Blood, 91, pp. 3163-3171.
7. Ramachandran, C. and Wellham, LL. (2003) Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Anticancer Res, 23, pp. 2681-2690.
8. Ueda, M., Pastan, I. and Gottesman, MM. (1987) Isolation and sequence of the promoter region of the human multidrug-resistance gene. J Biol Chem, 262, pp. 17432-17438.
9. Callaghan, R., Ford, RC and Kerr, ID. (2006) The translocation mechanism of P-glycoprotein. FEBS Lett, 580, pp. 1056-1063.
10. Breier, A., Barancik, M. and Sulova, Z. (2005) P-glycoprotein: implications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets, 5, pp. 457-468.
11. Xu, D., Lu, Q. and Hu, X. (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett, 243, pp. 274-280.
12. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, pp. 156-159.
13. Gao, P., Zhou, GY and Zhang, QH (2006) Reversal MDR in breast carcinoma cells by ribozyme designed according the secondary structure of mdr1 mRNA. Chin J Physiol, 49, pp. 96-103.
14. Sandhya, T. and Mishra, KP. (2006) Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett, 238, pp. 304-313.
15. Fruehauf, S., Breems, D. A. and Knaan-Shanzer, S. (1996) Frequency analysis of multidrug resistency-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area forming cell assay and detection of vector-mediated p-glycoprotein expression by rhodamine 123. Hum Gene Ther, 7, pp. 1219-1231.
16. Laible, G., Wagner, S. and Alderson, J. (2006) Oligonucleotide-mediated gene modification and its promise for animal agriculture. Gene, 366, pp. 17-26.
17. Thierry, AR and Dritschilo, A. (1992) Liposomal delivery of antisense oligodeoxynucleotides. Application to the inhibition of the multidrug resistance in cancer cells. Ann NY Acad Sci, 660, pp. 300-302.
18. Corrias, MV and Tonini, GP. (1992) An oligomer complementary to the 5′ end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res, 12, pp. 1431-1438.
19. Quattrone, A., Papucci, L. and Morganti, M. (1994) Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. Oncol Res, 6, pp. 311-320.
20. Thierry, AR, Rahman, A. and Dritschilo, A. (1993) Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem Biophys Res Commun, 190, pp. 952-960.
21. Li, J., Xu, LZ and He, KL (2001) Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Breast Cancer Res, 3, pp. 253-263.